This week Purdue Pharma settled with the state of Oklahoma for $270 million to avoid a trial charging the company with what I call opioid drug dealing. Purdue Pharma and members of the Sackler family–founders and managers of the company–are enmeshed in 1,600 cases throughout the U.S. They are accused of illegal marketing activities that led to over-prescribing and rampant distribution of Oxycontin, which paved the way for millions to the addiction of opioids, with hundreds of thousands dying over the last decade.
It was not just Purdue but many drug companies—and the entire
drug supply chain—that fueled the opioid death spiral. As drug companies and
their allies in the drug supply chain continue to use the opioid crisis as a
means to oppose prescription drug importation to lower drug prices in the U.S.,
we can only look on with amazement at their audacity.
(more…)Tagged with: New York Times, Purdue, Sackler family
Earlier this week, a report (the
“FGI Report”) opposing prescription drug importation proposals was released
by the law firm of Freeh, Sporkin and Sullivan LLP and the Freeh Group International.
Both organizations are headed by former FBI Director, Louis Freeh. I’m hesitant
to criticize reports authored by dedicated Americans who spent years in public
service protecting the safety of the American people in federal law enforcement.
On the other hand, the intent of tacking the name of a venerated American
patriot on a report that mirrors
the lobbying agenda of the pharmaceutical industry is clearly being used to
deter voices opposed to that agenda.
Summing it all up: this report was commissioned, I believe, by the drug company-funded group Partnership for Safe Medicines or a similar organization. As noted in the report’s title, it’s an addendum to an earlier report published in late 2017, one that was promoted at a Partnership for Safe Medicines media event at the National Press Club.
(more…)Tagged with: Alex Azar, FGI report, Louis Freeh, Partnership for Safe Medicines
Back in 2008, Consumer Reports recommended PharmacyChecker to Americans looking to save money on prescription drugs at foreign pharmacies. An article in the Los Angeles Times stated: “Consumer Reports Best Buy Drugs advises checking online prices, for U.S. and foreign pharmacies, at pharmacychecker.com.”
That was then. This is now.
When Consumer Reports’ Lisa Gill testified before the Senate
Special Committee on Aging hearing on drug prices last week, she was silent
in her prepared remarks about what she knows well: millions of Americans,
readers of Consumer Reports, buy medicine online internationally. Her silence
did not surprise me because Consumer Reports does not currently recommend
buying medicine online from Canada or other countries, although many of its
readers believe it should.
(more…)Tagged with: American Enterprise Institute, Consumer Reports